Centonza, A.; Mazza, T.; Trombetta, D.; Sparaneo, A.; Petrizzelli, F.; Castellana, S.; Centra, F.; Fabrizio, F.P.; Di Micco, C.M.; Benso, F.;
et al. Clinical and Molecular Traits of a Novel SPECC1L-ALK Fusion in a Patient with Advanced Non-Small Cell Lung Cancer. J. Pers. Med. 2024, 14, 670.
https://doi.org/10.3390/jpm14070670
AMA Style
Centonza A, Mazza T, Trombetta D, Sparaneo A, Petrizzelli F, Castellana S, Centra F, Fabrizio FP, Di Micco CM, Benso F,
et al. Clinical and Molecular Traits of a Novel SPECC1L-ALK Fusion in a Patient with Advanced Non-Small Cell Lung Cancer. Journal of Personalized Medicine. 2024; 14(7):670.
https://doi.org/10.3390/jpm14070670
Chicago/Turabian Style
Centonza, Antonella, Tommaso Mazza, Domenico Trombetta, Angelo Sparaneo, Francesco Petrizzelli, Stefano Castellana, Flavia Centra, Federico Pio Fabrizio, Concetta Martina Di Micco, Federica Benso,
and et al. 2024. "Clinical and Molecular Traits of a Novel SPECC1L-ALK Fusion in a Patient with Advanced Non-Small Cell Lung Cancer" Journal of Personalized Medicine 14, no. 7: 670.
https://doi.org/10.3390/jpm14070670
APA Style
Centonza, A., Mazza, T., Trombetta, D., Sparaneo, A., Petrizzelli, F., Castellana, S., Centra, F., Fabrizio, F. P., Di Micco, C. M., Benso, F., Tabbò, F., Righi, L., Merlini, A., Graziano, P., & Muscarella, L. A.
(2024). Clinical and Molecular Traits of a Novel SPECC1L-ALK Fusion in a Patient with Advanced Non-Small Cell Lung Cancer. Journal of Personalized Medicine, 14(7), 670.
https://doi.org/10.3390/jpm14070670
